PLx Pharma Inc. (PLXP) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
9 FISHERS LANE SPARTA, NJ 07871 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2022 MRQ | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 69,392 | 22,449 | 14,001 | 14,250 | 24,404 | 16,700 | |||
| Cash and cash equivalents | 69,392 | 22,449 | 14,001 | 14,250 | 24,404 | 16,675 | |||
| Other undisclosed cash, cash equivalents, and short-term investments | 25 | ||||||||
| Receivables | 634 | 19 | 18 | 19 | |||||
| Inventory, net of allowances, customer advances and progress billings | 2,458 | 100 | (500) | (1,003) | 246 | ||||
| Inventory | 2,458 | 100 | (500) | (1,003) | 246 | ||||
| Prepaid expense | 409 | 300 | 359 | ||||||
| Deferred costs | 2,458 | 143 | 175 | ||||||
| Deposits current assets | 4 | ||||||||
| Other undisclosed current assets | (1,466) | 293 | 763 | 1,016 | 716 | (25) | |||
| Total current assets: | 73,476 | 22,986 | 14,283 | 14,865 | 25,690 | 17,034 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 230 | 327 | 618 | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 858 | 1,226 | 1,467 | 1,394 | 1,030 | ||||
| Intangible assets, net (including goodwill), including: | 2,061 | 2,061 | 2,061 | 2,061 | 2,061 | ||||
| Goodwill | 2,061 | 2,061 | 2,061 | 2,061 | 2,061 | ||||
| Intangible assets, net (excluding goodwill) | 2,294 | ||||||||
| Other undisclosed intangible assets, net (including goodwill) | (2,294) | ||||||||
| Deposits noncurrent assets | 17 | 17 | 74 | 68 | 68 | ||||
| Other noncurrent assets | 57 | ||||||||
| Total noncurrent assets: | 3,166 | 3,631 | 4,219 | 3,523 | 3,159 | 57 | |||
| TOTAL ASSETS: | 76,642 | 26,617 | 18,503 | 18,388 | 28,849 | 17,091 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 10,600 | 863 | 929 | 653 | 852 | 2,122 | |||
| Interest and dividends payable | ✕ | 597 | 35 | 60 | |||||
| Employee-related liabilities | ✕ | 579 | |||||||
| Accrued liabilities | 1,040 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 10,600 | 265 | 894 | 593 | 852 | 503 | |||
| Debt | 622 | 3,658 | 2,910 | ||||||
| Other liabilities | 116 | 275 | 305 | 61 | 60 | ||||
| Other undisclosed current liabilities | 1,163 | 1,782 | 1,202 | 1,109 | 904 | ||||
| Total current liabilities: | 11,879 | 3,542 | 6,093 | 4,733 | 1,816 | 2,122 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 622 | 4,280 | 6,942 | ||||||
| Long-term debt, excluding current maturities | 622 | 4,280 | 6,942 | ||||||
| Liabilities, other than long-term debt | 12,954 | 9,825 | 8,657 | 2,622 | 15,385 | ||||
| Other liabilities | 136 | 134 | 409 | 84 | 142 | ||||
| Derivative instruments and hedges, liabilities | 12,818 | 9,691 | 8,248 | 2,537 | 15,243 | ||||
| Other undisclosed noncurrent liabilities | 129 | 2,796 | 1,560 | 309 | 90 | ||||
| Total noncurrent liabilities: | 13,083 | 12,621 | 10,840 | 7,211 | 22,416 | ||||
| Total liabilities: | 24,962 | 16,164 | 16,933 | 11,944 | 24,232 | 2,122 | |||
| Equity | |||||||||
| Equity, attributable to parent | 35,666 | (10,932) | (12,092) | 6,444 | 4,616 | 14,969 | |||
| Common stock | 28 | 14 | 9 | 9 | 9 | 11 | |||
| Additional paid in capital | 183,912 | 91,203 | 74,837 | 72,871 | 71,940 | 77,340 | |||
| Accumulated deficit | (148,274) | (102,149) | (86,938) | (66,436) | (67,332) | (62,383) | |||
| Other undisclosed equity | 16,014 | 21,385 | 13,662 | ||||||
| Total equity: | 51,680 | 10,453 | 1,570 | 6,444 | 4,616 | 14,969 | |||
| TOTAL LIABILITIES AND EQUITY: | 76,642 | 26,617 | 18,503 | 18,388 | 28,849 | 17,091 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2022 TTM | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 8,208 | 243 | 565 | 753 | 779 | |||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | 779 | ||
| Sublease income | 145 | 243 | 234 | ✕ | ✕ | ✕ | ||
| Cost of revenue | (4,805) | (771) | (320) | |||||
| Cost of goods and services sold | (771) | (320) | ||||||
| Gross profit: | 3,403 | 243 | 565 | (18) | 459 | |||
| Operating expenses | (44,193) | (13,490) | (14,768) | (11,714) | (16,626) | (21,368) | ||
| Other undisclosed operating income (loss) | (213) | 771 | 320 | |||||
| Operating loss: | (40,790) | (13,459) | (14,202) | (10,961) | (15,848) | (21,368) | ||
| Nonoperating income (expense) | (5,335) | (1,752) | 405 | 11,858 | (419) | |||
| Investment income, nonoperating | 405 | 298 | 112 | |||||
| Interest and debt expense | (308) | (995) | (1,146) | (1,165) | ||||
| Loss from continuing operations before equity method investments, income taxes: | (46,125) | (15,519) | (14,792) | (249) | (17,432) | (21,368) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 308 | (5,710) | 1,146 | 1,165 | ||||
| Income (loss) from continuing operations before income taxes: | (46,125) | (15,211) | (20,502) | 896 | (16,267) | (21,368) | ||
| Income tax expense (benefit) | (6,413) | (4,312) | (8,892) | (1,692) | 920 | |||
| Loss from continuing operations: | (52,538) | (19,522) | (29,394) | (795) | (15,347) | (21,368) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (52,538) | (19,522) | (29,394) | (795) | (15,347) | (21,368) | |
| Net loss: | (52,538) | (19,522) | (29,394) | (795) | (15,347) | (21,368) | ||
| Other undisclosed net income attributable to parent | 6,413 | 4,312 | 8,892 | 1,692 | 47 | |||
| Net income (loss) attributable to parent: | (46,125) | (15,211) | (20,502) | 896 | (15,347) | (21,321) | ||
| Preferred stock dividends and other adjustments | (2,525) | (1,737) | (13,751) | |||||
| Net income (loss) available to common stockholders, diluted: | (48,650) | (16,948) | (34,253) | 896 | (15,347) | (21,321) | ||
Comprehensive Income ($ in thousands)
| 9/30/2022 TTM | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (52,538) | (19,522) | (29,394) | (795) | (15,347) | (21,368) | ||
| Comprehensive loss, net of tax, attributable to parent: | (52,538) | (19,522) | (29,394) | (795) | (15,347) | (21,368) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.